|
Delayed
Sao Paulo
01:38:00 31/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 84.00 BRL | +13.53% |
|
+27.12% | +46.52% |
| 10:18pm | Dr Reddy's gets tentative US FDA nod for generic HIV prevention | RE |
| 30/10 | Gilead's HIV Franchise Supports Growth Outlook, RBC Says | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| GILEAD SCIENCES, INC. | Other Pharmaceuticals | +13.53% | +27.12% | +46.52% | +56.56% | +171.57% | 21TCr |
-
|
-
|
-
|
- Stock Market
- Stocks
- GILD Stock
- GILD34 Stock
- Charts Gilead Sciences, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
